ZHBIO(SZ:300653)2023-07-04 08:18Market Overview - The dental implant market showed significant recovery in the first half of 2023, with sales impacted by the pandemic and holiday effects, resulting in a year-on-year decline of 7.35% in overall revenue for Q1 [1] - Despite a temporary drop in demand due to centralized procurement policies, the market is expected to have substantial growth potential in the future, influenced by procurement outcomes and consumer purchasing power [1] Product-Specific Insights - The company successfully continued its procurement for artificial dura mater in Jiangsu province, with a decrease in prices due to centralized procurement leading to increased sales [2] - Active biological bone products are included in the centralized procurement scope, but specific execution plans have not yet been released [3] - The company's oral repair membranes have not been subjected to centralized procurement, maintaining a strong market position [4] Research and Development - Ongoing clinical trials include calcium silicate bio-ceramic bone repair materials, breast patches, and uterine repair membranes, with recent completion of nationwide enrollment for the calcium silicate product [5] Financial and Operational Updates - In 2022, travel and related expenses decreased due to external factors, while 2023 has seen a normalization of offline meetings and marketing activities [6] - The company is committed to improving its compensation and incentive mechanisms to attract and retain talent, with stock incentive plans being an integral part of its strategy [6] Communication and Disclosure - The company ensured thorough communication with investors, adhering to its information disclosure management policies to guarantee the accuracy and timeliness of information shared [6]